PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

61.39
-0.02
-0.03%
Closed 16:00 07/10 EDT
OPEN
61.32
PREV CLOSE
61.41
HIGH
61.52
LOW
60.94
VOLUME
20.06K
TURNOVER
--
52 WEEK HIGH
68.02
52 WEEK LOW
46.90
TOTAL ASSET
231.86M
YTD YIELD
-3.33%
1D
5D
1M
3M
1Y
5Y

PPH News

More
Eli Lilly Q1 Earnings Call Key Takeaways
Seeking Alpha - Article · 04/27 11:22
Sanders' big Nevada primary win shakes health-related stocks
Seeking Alpha - Article · 02/24 15:10
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10 14:35
Investing In The Prospect Of Drug Pricing Reforms
Seeking Alpha - Article · 02/06 12:29
The Trouble With Pharma
Seeking Alpha - Article · 12/31/2019 08:25
Quality Play With Pharma ETFs
Seeking Alpha - Article · 12/11/2019 20:05
Pharma Still Stressed
Seeking Alpha - Article · 11/25/2019 17:43
FDA OK'd record number of generic drugs in F19
Seeking Alpha - Article · 10/16/2019 16:42

Profile

Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
MVIS US Listed Pharmaceutical 25 NR USD*100.0%
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Hao-Hung (Peter) Liao, George Chao, Guo Hua (Jason) Jin

Asset Allocation

229.34M
  • 99.8758%
  • 0.00%
  • 0.1242%
  • 0.00%

2020 Q2

229.34M

2020 Q1

181.72M

2019 Q4

200.78M

2019 Q2

176.91M

2019 Q1

190.29M

Dividend History

Ex-Div Date
Dividend Per Share
07/01/2020
0.2523
04/01/2020
0.3374
12/30/2019
0.1729
10/01/2019
0.2920
07/01/2019
0.2810
More